Gilead Sciences Inc. is acquiring Santa Monica- based biotech firm Kite Pharma Inc., which specializes in the emerging field of cell therapy in which a patient’s own immune cells are used to fight cancer, the companies announced Monday. Gilead, which is based in Northern California, will acquire Kite for $180 per share in cash. The […]